| Phuong Thi Bich Nguyen, RPH | |
|
304 W Huntington Dr, Monrovia, CA 91016-3304 | |
| (626) 359-6191 | |
| Not Available |
| Full Name | Phuong Thi Bich Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 304 W Huntington Dr, Monrovia, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629370325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 64905 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Phuong Thi Bich Nguyen, RPH 4413 Richwood Ave # C, El Monte, CA 91732-1900 Ph: (626) 454-4771 | Phuong Thi Bich Nguyen, RPH 304 W Huntington Dr, Monrovia, CA 91016-3304 Ph: (626) 359-6191 |
News Archive
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
Researchers at the University of Colorado School of Medicine have found that lack of a specific gene interrupts neural tube closure, a condition that can cause death or paralysis.
Use of the International Classification of Functioning, Disability and Health (ICF) has increased significantly over the last decade. The current issue of NeuroRehabilitation features a series of insightful articles that provide examples of how the ICF can be successfully implemented in clinical practice and research related to neurorehabilitation, ultimately benefiting patient care.
For cancer therapy, treatment resistance poses a major hurdle. Even aggressive treatments such as immunotherapies or nanomedicines may fail to eliminate all cancer cells, allowing new mutations to develop that may cause relapse.
Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.
› Verified 2 days ago
Julia Bui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 W Foothill Blvd, Monrovia, CA 91016 Phone: 626-357-1818 Fax: 626-357-1168 | |
Henry Hung Yat Chang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2035 S Myrtle Ave, Monrovia, CA 91016 Phone: 626-590-6666 | |
Hoang Phung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 W Foothill Blvd, Monrovia, CA 91016 Phone: 626-357-1818 | |
Cindy Quitoriano, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 347 W Lemon Avnenue, Monrovia, CA 91016 Phone: 626-484-3520 | |
Leah Uyen Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 607 Parkrose Ave, Monrovia, CA 91016 Phone: 626-348-4452 | |
Dr. Karen Rita Wan, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 W Foothill Blvd, Monrovia, CA 91016 Phone: 626-476-8768 | |
Yang Xu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2035 S Myrtle Ave, Monrovia, CA 91016 Phone: 626-476-3511 |